Vitamed, Rekah Group
Generic Pharmaceutical Manufacturing
Startup Public Health Tech & Life Sciences Est. 1947
Total Raised
Undisclosed
Public
Last Round
Undisclosed
1 rounds
Team
3
11-50 employees
Confidence
98/100
News
6
articles
Patents
1
About
Vitamed is a generic pharmaceutical manufacturer and part of Rekah Pharmaceutical Industries. Vitamed is working to increase its international presence by focusing on out-licensing, in-licensing, establishing new partnerships, and executing mergers and acquisitions. Rekah Group is active at all levels of the value chain: production, R&D, marketing, sales, distribution, import, and export. The portfolio, which includes a wide range of 280 generic prescription and over-the-counter drugs, dermo-cosmetics, vitamins, and nutritional supplements, focuses on four core fields: steroids, antibiotics, ophthalmic medications, and over-the-counter drugs. The group operates research and development laboratories at its production sites in Holon and Binyamina.
Classification
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentCosmetic Materials
Core Technology
Materials & Substances
Target Customer
Healthcare & Life SciencesLife SciencesCosmeticsPharmaceuticalsHealthcarePatientsProviders
Business Model
B2CB2B2CB2B
Tags
vitaminssupplementsgeneric-drugscosmeticsmedicationpharmaceuticalsmanufacturingpatientspharma-companies
Funding & Events
Jan 1994
Exit Undisclosed
News (6)
Sep 9, 2025 · sg.finance.yahoo.com
growth-positive
Nifty clocks fifth session of gains led by IT on Infosys buyback, US rate cut hopes
Sep 9, 2025 · finance.yahoo.com
growth-positive
Nikkiso Addresses Growing Ammonia-Handling Demand and Launches Next-Generation Pump at Gastech 2025
Product Stage
growth-positive
Westin Desaru Coast Resort partners with CAYIN Technology for digital signage
Partners
Sep 9, 2025 · finance.yahoo.com
growth-positive
BHP Xplor Opens Applications for 2026 Cohort, Offering Equity-Free Funding and Global Support
Partners
Sep 9, 2025 · finance.yahoo.com
growth-positive
Assessing the Valuation of Yue Yuen Industrial (SEHK:551) After Recent Volatility
Aug 27, 2018 · en.globes.co.il
growth-positive
Rekah to take over some Teva Israel production
PartnersLayoffs
Details
Product Stage
Released
Employees
11-50
Exact Count
34
District
Center District
Founded
1947
Registrar
520042003
Crunchbase
rekah-pharmaceutical-industry
Locations
HaMelacha Street 30, Holon, Israel
Links
Website
LinkedIn
Admin
Last Update
Sep 7, 2024
Verified by
Yanina Wainscheinker
Claimed
Yes
Missing
markets
Team (3)
Guy Zangi
VP Sales & BD
Jack Azran
General Manager
Einat Natanson
Marketing Manager
Internal
Created by
Raz Zohar (raz@platterz.ca)
Created
2014-11-13T00:00:00.000Z
Last editor
Orli Wollner (orlushka@gmail.com)
Status
Public on TASE on Jan, 1994;